Company / Gross Profit per Share
Insulet Corporation Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$27.64
FY2025
5-year range
$11.39 / $27.64
FY2021-FY2025
Trend
+33.6%
vs FY2024
Sector context
#12 of 94
Health Care
What the data says
Insulet Corporation's gross profit per share of $27.64 is higher than 87% of companies in the Health Care sector (FY2025). Gross Profit per Share has increased for 9 consecutive years, from $3.71 in FY2016 to $27.64 in FY2025.
Based on SEC 10-K filings.
27.64 in FY2025 with a 5-year CAGR of +24.4%. Top quartile in the Health Care sector.
Improved from $16.69 to $27.64 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +33.4%
- 5-Year CAGR
- +24.4%
- 10-Year CAGR
- -
Sector benchmark
+93.4% above sector average
Key checks
Key Insights
- Insulet Corporation's gross profit per share has grown for 9 consecutive years.
- In FY2025, gross profit per share increased 33.6% year-over-year.
- Ranks #12 out of 94 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.64 | +33.6% |
| FY2024 | $20.68 | +23.9% |
| FY2023 | $16.69 | +43.3% |
| FY2022 | $11.65 | +2.2% |
| FY2021 | $11.39 | +22.6% |
| FY2020 | $9.29 | +14.5% |
| FY2019 | $8.11 | +27.8% |
| FY2018 | $6.35 | +31.6% |
| FY2017 | $4.82 | +30.2% |
| FY2016 | $3.71 | +56.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026